Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
WOOF
|
Michelle Bonfilio
Chief Human Resources Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 1.74% |
$9,000
$18.0 p/Share
|
Jan 19
2021 |
WOOF
|
Justin Tichy
Chief Operating Officer |
BUY
Open market or private purchase
|
Direct | 1,500 Added 2.29% |
$27,000
$18.0 p/Share
|
Jan 19
2021 |
WOOF
|
Ron Coughlin
CEO & Chairman |
BUY
Open market or private purchase
|
Indirect | 1,200 Added 50.0% |
$21,600
$18.0 p/Share
|
Jan 19
2021 |
WOOF
|
Ilene Eskenazi
Officer |
BUY
Open market or private purchase
|
Direct | 4,000 Added 11.18% |
$72,000
$18.0 p/Share
|
Jan 19
2021 |
WOOF
|
Tariq Hassan
Chief Marketing Officer |
BUY
Open market or private purchase
|
Indirect | 500 Added 50.0% |
$9,000
$18.0 p/Share
|
Jan 19
2021 |
WOOF
|
John Zavada
Chief Admin. Officer |
BUY
Open market or private purchase
|
Direct | 1,500 Added 3.36% |
$27,000
$18.0 p/Share
|
Jan 19
2021 |
DRIO
|
Erez Raphael
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 2,268 Added 0.43% |
-
|
Jan 19
2021 |
DRIO
|
Adam K Stern
Director |
BUY
Open market or private purchase
|
Direct | 43,850 Added 39.17% |
-
|
Jan 19
2021 |
CMPI
|
Arthur M Krieg
Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.07% |
$6,545
$13.09 p/Share
|
Jan 19
2021 |
YAYO
|
John Gray
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 152,267 Added 40.67% |
$234,491
$1.54 p/Share
|
Jan 19
2021 |
UONE
|
Eric Semler
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 4.31% |
$172,000
$1.72 p/Share
|
Jan 19
2021 |
UONE
|
Eric Semler
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 12.9% |
$657,000
$6.57 p/Share
|
Jan 19
2021 |
ATER
|
9830 Macarthur LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 600 Added 0.01% |
$12,300
$20.5 p/Share
|
Jan 19
2021 |
NTRS
|
Becerra Jose Luis Prado
Director |
BUY
Open market or private purchase
|
Indirect | 3 Added 0.0% |
$292
$97.41 p/Share
|
Jan 19
2021 |
REPL
|
Colin Love
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 7,857 Reduced 0.82% |
$336,437
$42.82 p/Share
|
Jan 19
2021 |
PCVX
|
Robert Lorne Hopfner
Director |
SELL
Open market or private sale
|
Indirect | 49,516 Reduced 1.28% |
$1,277,513
$25.8 p/Share
|
Jan 19
2021 |
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 0.8% |
$990,500
$19.81 p/Share
|
Jan 19
2021 |
REPL
|
Philip Astley Sparke
Director |
SELL
Open market or private sale
|
Direct | 8,432 Reduced 0.67% |
$360,721
$42.78 p/Share
|
Jan 19
2021 |
REPL
|
Pamela Esposito
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 5,727 Reduced 3.15% |
$245,173
$42.81 p/Share
|
Jan 19
2021 |
ABEO
|
Sco Capital Partners LLC
Director |
SELL
Open market or private sale
|
Indirect | 207,117 Reduced 1.75% |
$430,803
$2.08 p/Share
|
Jan 19
2021 |
SNEX
|
Sean Michael Oconnor
Executive Vice-Chairman-Board |
SELL
Open market or private sale
|
Direct | 1,807 Reduced 0.56% |
$108,420
$60.0 p/Share
|
Jan 19
2021 |
W
|
Edmond Macri
Chief Product/Marketing |
SELL
Open market or private sale
|
Direct | 1,346 Reduced 42.04% |
$403,396
$299.7 p/Share
|
Jan 19
2021 |
W
|
Michael D Fleisher
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,534 Reduced 5.16% |
$1,679,624
$303.51 p/Share
|
Jan 19
2021 |
W
|
Steve Oblak
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 895 Reduced 0.64% |
$270,380
$302.1 p/Share
|
Jan 19
2021 |
EGHT
|
Samuel C. Wilson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 99 Reduced 0.06% |
$3,750
$37.88 p/Share
|
Jan 19
2021 |
EGHT
|
Dejan Deklich
Chief Products Officer |
SELL
Open market or private sale
|
Direct | 96 Reduced 0.05% |
$3,636
$37.88 p/Share
|
Jan 19
2021 |
EGHT
|
Germaine Cota
Chief Accting Off./Treasurer |
SELL
Open market or private sale
|
Direct | 73 Reduced 0.11% |
$2,765
$37.88 p/Share
|
Jan 19
2021 |
EGHT
|
Matthew Zinn
SVP-CLO, Secretary |
SELL
Open market or private sale
|
Direct | 68 Reduced 0.14% |
$2,498
$36.73 p/Share
|
Jan 19
2021 |
EGHT
|
Bryan R Martin
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 56 Reduced 0.08% |
$2,057
$36.73 p/Share
|
Jan 19
2021 |
TRUE
|
Charles C. Thomas
VP, Controller, PAO |
SELL
Open market or private sale
|
Direct | 489 Reduced 0.65% |
$2,259
$4.62 p/Share
|
Jan 19
2021 |
COHR
|
Vincent D Mattera Jr
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 8,500 Reduced 2.0% |
$783,955
$92.23 p/Share
|
Jan 19
2021 |
AMK
|
Gary G. Zyla
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.12% |
$5,034
$25.17 p/Share
|
Jan 19
2021 |
ADAP
|
Elliot Norry
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,111 Reduced 37.36% |
$11,969
$5.67 p/Share
|
Jan 19
2021 |
ADAP
|
John Lunger
Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct | 4,358 Reduced 37.24% |
$24,710
$5.67 p/Share
|
Jan 19
2021 |
ADAP
|
Adrian Rawcliffe
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,879 Reduced 42.2% |
$56,014
$5.67 p/Share
|
Jan 19
2021 |
MIME
|
Neil Murray
Director |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 3.35% |
$1,548,750
$44.25 p/Share
|
Jan 19
2021 |
TRU
|
John T Danaher
President, Consumer Inter |
SELL
Open market or private sale
|
Direct | 21,178 Reduced 49.49% |
$1,938,634
$91.54 p/Share
|
Jan 19
2021 |
TEN
|
Icahn Carl C
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 11,411 Reduced 0.14% |
$122,782
$10.76 p/Share
|
Jan 19
2021 |
SCPE
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 26,238 Reduced 1.49% |
$271,301
$10.34 p/Share
|
Jan 19
2021 |
WM
|
John C Pope
Director |
SELL
Open market or private sale
|
Direct | 301 Reduced 0.55% |
$34,856
$115.8 p/Share
|
Jan 19
2021 |
EQIX
|
Sara Baack
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 1,965 Reduced 14.56% |
$1,410,025
$717.57 p/Share
|
Jan 19
2021 |
EQIX
|
Keith D Taylor
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,291 Reduced 14.44% |
$2,363,168
$718.07 p/Share
|
Jan 19
2021 |
EQIX
|
Michael Earl Campbell
Chief Sales Officer |
SELL
Open market or private sale
|
Direct | 2,111 Reduced 23.38% |
$1,513,819
$717.11 p/Share
|
Jan 19
2021 |
EQIX
|
Brandi Galvin Morandi
Chief People Officer |
SELL
Open market or private sale
|
Direct | 2,608 Reduced 13.8% |
$1,871,996
$717.79 p/Share
|
Jan 19
2021 |
EQIX
|
Peter Van Camp
Executive Chairman |
SELL
Open market or private sale
|
Direct | 1,892 Reduced 20.34% |
$1,358,872
$718.22 p/Share
|
Jan 19
2021 |
EQIX
|
Karl Strohmeyer
Chief Customer & Rev Officer |
SELL
Open market or private sale
|
Direct | 3,020 Reduced 24.45% |
$2,168,028
$717.89 p/Share
|
Jan 19
2021 |
EQIX
|
Charles J Meyers
Director |
SELL
Open market or private sale
|
Direct | 4,947 Reduced 28.32% |
$3,546,900
$716.98 p/Share
|
Jan 19
2021 |
IBKR
|
Thomas Aj Frank
Executive Vice President |
SELL
Open market or private sale
|
Direct | 18,337 Reduced 1.39% |
$1,283,040
$69.97 p/Share
|
Jan 19
2021 |
IBKR
|
Paul Jonathan Brody
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 2,558 Reduced 0.96% |
$178,983
$69.97 p/Share
|
Jan 19
2021 |
SNAP
|
Derek Andersen
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 8,662 Reduced 0.69% |
$436,825
$50.43 p/Share
|
Jan 19
2021 |